Left Ventricular Hypertrophy and Diastolic Dysfunction
Our understanding of systemic hypertension and its vascular complications has been expanding steadily in the past two decades. This progress has refined methods for the measurement of hypertensive disease complications and allowed an inquiry into the clinical factors that may accelerate them. The heart is a prime target for hypertensive damage, suffering accelerated coronary atherosclerosis, left ventricular hypertrophy (LVH), arrhythmias, and congestive heart failure (CHF) (1).
KeywordsLeave Ventricular Hypertrophy Diastolic Dysfunction Left Atrial Left Ventricular Mass Left Ventricular Mass Index
Unable to display preview. Download preview PDF.
- 2.White WB (1994) Hypertensive target organ involvement and 24-hour ambulatory blood pressure measurement. In: Waeber B, Brunner H, eds. Ambulatory Blood Pressure Monitoring, New York: Raven.Google Scholar
- 3.Devereux RB (1990) Hypertensive cardiac hypertrophy. In: Hypertension, Pathophysiology, Diagnosis and Management. Laragh JH, Brenner BM, eds, New York: Raven.Google Scholar
- 5.Devereux RB, Okin PM, Roman MJ (1998) Pre-clinical cardiovascular disease and surrogate end-points in hypertension: does race influence target organ damage independent of blood pressure? Ethnicity Dis 8: 134–148.Google Scholar
- 8.Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The Sixth Report (1997) Arch Intern Med 157: 2413–2446.Google Scholar
- 15.European Study Group on Diastolic Heart Failure (1998) How to diagnose diastolic heart failure. Eur Heart J 19: 990–1003.Google Scholar